Clinical Trial: Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)

U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06372119) titled 'Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)' on Dec. 27, 2023.

Brief Summary: The goal of this randomized clinical trial is to evaluate the effectiveness of the letrozole-stimulated cycle strategy versus the artificial cycle strategy for endometrial preparation in women with irregular menstrual cycles after one cycle of endometrial preparation. The primary question it aims to answer is:

* Does the letrozole-stimulated cycle strategy for endometrial preparation result in a higher live birth rate compared to the artificial cycle strategy in women with irregular menstrual cycles after one cycle of e...